A paper by Kei Sato’s group (Division of Systems Immunology) was published in The Lancet Infectious Diseases.

Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant

Keiya Uriu, Jumpei Ito, Jiri Zahradnik, Shigeru Fujita, Yusuke Kosugi, Gideon Schreiber, The Genotype to Phenotype Japan (G2P-Japan) Consortium, and Kei Sato

Lancet. Infect. Dis. 2023 Jan 31. doi: 10.1016/S1473-3099(23)00051-8.